Sinolink Securities Co., Ltd. (hereinafter referred to as "Sinolink Securities" or the "Sponsor"), as the sponsor and continuous supervisor for the non-public offering of A-shares by Wuhan Mindray Bio-Medical Electronics Co., Ltd. (hereinafter referred to as "Mindray Bio" or the "Company"), has conducted a verification in accordance with the "Administrative Measures for the Sponsorship of Securities Issuance and Listing," "Regulatory Rules for the Management of Raised Funds of Listed Companies," "Stock Listing Rules of the Shenzhen Stock Exchange," and the "Self-Regulatory Guidelines for Listed Companies on the Shenzhen Stock Exchange No. 1 — Standardized Operation of Main Board Listed Companies." The verification covers the Company's decision to terminate the "Medical Health Information Project" and use the remaining raised funds, together with the accumulated wealth management income and interest income generated from the special account for raised funds (the final amount shall be subject to the balance on the date of deliberation and approval by the Company's general meeting of shareholders), for the acquisition of 100% equity of Wuhan Biker Rescue Supplies Co., Ltd. (hereinafter referred to as "Wuhan Biker," "Biker," or the "Target Company"). The verification findings and opinions regarding the termination of partial raised-fund investment projects and the change in the use of raised funds are as follows:
I. Basic Information on Raised Funds
Approved by the China Securities Regulatory Commission's "Reply on Approving the Non-public Offering of Shares by Wuhan Mindray Bio-Medical Electronics Co., Ltd." (Zheng Jian Xu Ke [2021] No. 1859), the Company conducted a non-public offering of 8,259,846 RMB ordinary shares (A-shares). The total amount of raised funds was 466,103,109.78 RMB. After deducting issuance expenses of 6,261,109.77 RMB, the actual net proceeds were 459,842,000.01 RMB. The aforementioned raised funds were fully deposited into a special account for raised funds and managed accordingly. This has been verified by Lixin Certified Public Accountants (Special General Partnership), which issued the "Capital Verification Report" (Xin Hui Shi Bao Zi [2021] No. ZE10585).
II. Use of Raised Funds
As of June 30, 2026, the specific usage of the Company's raised funds is as follows:
| Project | Total Committed Investment | Adjusted Total Investment | Accumulated Investment | Investment Progress | Raised Fund Account Balance (Including Interest) |
|---|---|---|---|---|---|
| In Vitro Diagnostic Product Construction Project | 20,410.65 | 21,522.74 | 16,054.03 | 74.59% | 7,316.73 |
| Medical Health Information Project | 12,073.55 | 12,073.55 | 2,052.91 | 17.00% | 10,984.09 |
| Supplementary Working Capital | 13,500.00 | 13,500.00 | 13,500.00 | 100.00% | 0.00 |
| Total | 45,984.20 | 47,096.29 | 31,606.94 | 67.11% | 18,300.82 |
III. Relevant Circumstances and Reasons for Terminating Partial Raised-Fund Projects and Changing the Use of Raised Funds
(I) Circumstances of the Change in Use of Raised Funds
To improve the efficiency of the use of raised funds and in combination with changes in the policy environment and corporate development needs, the Company intends to terminate the "Medical Health Information Project" and change its use. The Company will use all 100.2064 million RMB of raised funds for this project and the interest of 9.6345 million RMB accrued as of the date of this announcement (the final amount shall be subject to the balance on the date of deliberation and approval by the Company's general meeting of shareholders) to acquire 100% equity of Wuhan Biker. The situation after the change of the non-public offering fund-raising project is as follows:
Unit: 10,000 RMB
| Project | Proposed Investment Amount Before Change | Change in Proposed Investment Amount | Proposed Investment Amount After Change | Change Description |
|---|---|---|---|---|
| In Vitro Diagnostic Product Construction Project | 21,522.74 | - | 21,522.74 | |
| Medical Health Information Project | 12,073.55 | -10,020.64 | 2,052.91 | Terminated and use changed |
| Supplementary Working Capital | 13,500.00 | - | 13,500.00 | |
| Acquisition of 100% Equity of Wuhan Biker Rescue Supplies Co., Ltd. | - | 10,020.64 | 10,020.64 | New investment project |
| Total | 47,096.29 | - | 47,096.29 |